GPCR Therapeutics, Inc. acquires Burixafor

On November 24, 2020, GPCR Therapeutics, Inc. acquired Burixafor, a life science company in South Korea.

Deal at a glance

AnnouncedNovember 24, 2020 TypeAdd-on Acquistion TargetBurixafor Buyer GPCR Therapeutics, Inc. SectorLife Science LocationSouth Korea ValueNot disclosed

Target company

Burixafor

South Korea

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

GPCR Therapeutics, Inc.

Company · 1 deal on record

1st transaction in life science
1st transaction in South Korea

1deals, all time

1in this sector

2020latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Questions about this deal

Who acquired Burixafor?GPCR Therapeutics, Inc. acquired Burixafor on November 24, 2020.

What type of deal was it?It was a add-on acquistion in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).